- Home
- MRSN vs TBRG Comparison
MRSN vs TBRG Comparison
Compare MRSN & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- TBRG
- Stock Information
- Founded
- MRSN 2001
- TBRG 1979
- Country
- MRSN United States
- TBRG United States
- Employees
- MRSN N/A
- TBRG N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- TBRG
- Sector
- MRSN Health Care
- TBRG
- Exchange
- MRSN Nasdaq
- TBRG NYSE
- Market Cap
- MRSN 252.0M
- TBRG 271.5M
- IPO Year
- MRSN 2017
- TBRG N/A
- Fundamental
- Price
- MRSN $0.62
- TBRG $22.93
- Analyst Decision
- MRSN Buy
- TBRG Buy
- Analyst Count
- MRSN 6
- TBRG 3
- Target Price
- MRSN $6.00
- TBRG $14.67
- AVG Volume (30 Days)
- MRSN 7.3M
- TBRG 93.6K
- Earning Date
- MRSN 02-26-2025
- TBRG 02-27-2025
- Dividend Yield
- MRSN N/A
- TBRG N/A
- EPS Growth
- MRSN N/A
- TBRG N/A
- EPS
- MRSN N/A
- TBRG N/A
- Revenue
- MRSN $34,837,000.00
- TBRG $337,674,000.00
- Revenue This Year
- MRSN N/A
- TBRG $1.02
- Revenue Next Year
- MRSN N/A
- TBRG $6.06
- P/E Ratio
- MRSN N/A
- TBRG N/A
- Revenue Growth
- MRSN N/A
- TBRG 0.26
- 52 Week Low
- MRSN $0.56
- TBRG $7.55
- 52 Week High
- MRSN $6.28
- TBRG $23.32
- Technical
- Relative Strength Index (RSI)
- MRSN 20.37
- TBRG 81.57
- Support Level
- MRSN $0.56
- TBRG $20.62
- Resistance Level
- MRSN $1.45
- TBRG $23.32
- Average True Range (ATR)
- MRSN 0.14
- TBRG 0.80
- MACD
- MRSN -0.06
- TBRG 0.18
- Stochastic Oscillator
- MRSN 6.49
- TBRG 91.61
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.